Nano-X Imaging (NASDAQ:NNOX) Announces Quarterly Earnings Results

Nano-X Imaging (NASDAQ:NNOX) announced its quarterly earnings data on Wednesday, September 9th. The company reported ($0.79) EPS for the quarter, missing the consensus estimate of ($0.16) by ($0.63), Zacks reports. Nano-X Imaging had a negative net margin of 926.05% and a negative return on equity of 116.93%. The business had revenue of $4.16 million during the quarter, compared to the consensus estimate of $5.38 million.

Here are the key takeaways from Nano-X Imaging’s conference call:

• Commercialization expanded with Nanox.ARC installations at RadNet, an orthopedic IDN, urgent care, and the first Nanox Imaging Network site in Philadelphia; the company reported some sites completing hundreds of scans monthly and 10 U.S. distribution partnerships.
• The Nanox Imaging Network has begun receiving insurer payments of approximately $200–$700 per claim, while management estimates potential annual revenue of roughly $500,000 to $1 million per site depending on utilization and reimbursement. A new CMS code for AI analysis of coronary and aortic valve calcification may also support Nanox.AI adoption.
• Q2 revenue increased 37% year over year to $4.2 million, driven largely by the acquired Nanox Health IT business and continued growth in teleradiology, which averaged 14% year-over-year growth in the first half of 2026.
• Financial losses and liquidity pressures remain significant: adjusted EBITDA loss widened to $11.3 million, cash and restricted deposits fell to $31.4 million from $60 million at year-end, and the company recorded a $40.7 million non-cash impairment charge. Nanox subsequently raised $8.5 million through equity offerings and said it expects to continue seeking additional capital.
• Management acknowledged that commercialization has taken longer than expected and announced workforce and manufacturing reductions, including a 15% cut among Israeli employees and a two-thirds reduction in Korea, where chip production was idled. The company expects about $2 million in annualized savings beginning in 2027, while shifting production to third-party suppliers and preparing to sell its Korean facility.

Nano-X Imaging Price Performance

NNOX opened at $0.33 on Friday. The business’s 50-day moving average is $0.63 and its two-hundred day moving average is $1.61. Nano-X Imaging has a 1 year low of $0.28 and a 1 year high of $4.71. The firm has a market capitalization of $25.94 million, a PE ratio of -0.15 and a beta of 1.28.

Insider Activity at Nano-X Imaging

In other news, Director Dan S. Suesskind purchased 60,000 shares of the firm’s stock in a transaction on Monday, September 14th. The stock was acquired at an average cost of $0.76 per share, with a total value of $45,600.00. Following the completion of the transaction, the director owned 110,000 shares in the company, valued at $83,600. This represents a 120.00% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders have bought 114,443 shares of company stock worth $81,276 over the last ninety days. Corporate insiders own 7.74% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently weighed in on NNOX. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nano-X Imaging in a report on Friday, October 2nd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $5.00 price objective on shares of Nano-X Imaging in a research note on Monday, August 17th. Finally, Alliance Global Partners downgraded shares of Nano-X Imaging from a “buy” rating to a “neutral” rating and cut their target price for the company from $5.00 to $3.00 in a research report on Tuesday, July 7th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $4.33.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. is an Israel-based medical technology company focused on expanding access to diagnostic imaging. The company develops digital X-ray systems and related technologies designed to provide medical imaging in locations that may have limited access to conventional radiology equipment.

Its primary product is the Nanox.ARC, a digital tomosynthesis system intended to generate two- and three-dimensional medical images using a proprietary cold-cathode X-ray source. Nano-X also offers the Nanox.CLOUD platform, which is designed to connect imaging devices with radiologists and other healthcare professionals for image interpretation, workflow management, and related services.